Decisions 4th April 2017


At the meeting that took place on 4th April, the folllowing decisions were agreed.

 

New Drug Requests

Approved

MUSE (No SCP)

 

Actilyse (alteplase)

  • for use in blocked haemodialysis catheters

Further Information required

Methenamine

  • Further information about the intended cohort is required.

Shared Care Protocols/TLS Change in Status

 

Tetracosactide 250mcg Injection TLS change Red to Amber

  • TLS to remain Red

Fosfomycin TLS change Amber (No SCP) to Green

  • Agreed for type 1 penicillin allergic patients

Melatonin for specialist paediatric population

  • Proposed SCP reviewed, further cohort definition required

Ferracru

  • Propsed SCP reviewed, clarification of monitoring responsibilities  and changes to contract to reflect changes inactivity required

Testosterone Injection

  • Paediatric for Constitutional Delay of Growth and Puberty
  • SCP reviewed, to be reviewed by Paediatric Joint Formulary Group
  • Further information about impact on primary care required

Ticagrelor SCP update

  • Updated to reflect TA420

 

Last updated by: Emily Knight on 14-06-2017 14:56